Venous leg ulcers (VLUs) place a significant economic burden on the NHS and have a significant effect on patients’ quality of life. The cost of managing a VLU was recently estimated to be a mean of £13,455 per annum (Guest et al, 2018). An evaluation was undertaken in a community NHS trust to determine the clinical outcomes, including healing time and symptom reduction, in eight patients with non-healing VLUs despite following best practice including compression therapy, using a single-use electroceutical therapy device. Clinician feedback was also considered. The patients experienced a significant improvement in all aspects, resulting in fewer dressings and less nursing time. Development of a pathway for using electroceutical therapy for the management of VLUs ensures the right treatment is given at the right time to reduce pain and improve healing for patients and reduce costs to the NHS.